Solvent method for forming a polymer scaffolding
US-2015359647-A1 · Dec 17, 2015 · US
US9610387B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9610387-B2 |
| Application number | US-201615170618-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 1, 2016 |
| Priority date | Jun 13, 2014 |
| Publication date | Apr 4, 2017 |
| Grant date | Apr 4, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods of making polymeric devices, such as stents, with one or more modifications such as addition of plasticizers, to improve processing, and the devices made by these methods.
Opening claim text (preview).
What is claimed is: 1. A method of fabricating a medical device, the method comprising: processing a polymer to form a medical device or a polymer construct, the processing occurring at a high temperature, the high temperature being above the melting temperature of the polymer, if the polymer exhibits a melting temperature above 35° C., or if the polymer does not exhibit a melting temperature above 35° C., at a temperature higher than 100° C. above the glass transition temperature (Tg) of the polymer, or higher than 75° C., if 75° C. is greater than 100° C. above the Tg of the polymer; adding a plasticizer to the polymer prior to, during, or both prior to and during the processing of the polymer; wherein the plasticizer is different from any solvent used in production of the polymer; removing at least 75 weight % of the plasticizer from the processed polymer, the removal comprising heating the processed polymer to and maintaining the processed polymer at a temperature above the glass transition temperature of the polymer or above 28° C., if the glass transition temperature of the polymer is lower than 25° C., and below the melting temperature of the polymer, if the polymer has a melting temperature above 28° C., or if the polymer does not have a melting temperature above 28° C., below the temperature that is 75° C. greater than the glass transition temperature of the polymer, or below 60° C., if 60° C. is higher than 75° C. greater than the glass transition temperature of the polymer; optionally executing one or more additional processing operations on the medical device or on the polymer construct; wherein the polymer has a number average molecular weight as measured by GPC using polystyrene standards of at least 250,000 g/mole, but not more than 3,000,000 g/mole, the polymer has a weight average molecular weight of at least 300,000 g/mole but not more than 4,500,000 g/mole, an inherent viscosity of at least 3.3 dl/g, but not more than 15 dl/g, or a combination thereof; wherein the polymer that is processed optionally comprises another material in addition to the plasticizer; and wherein if the polymer construct is formed, at least one additional processing operation is executed to form a medical device from the polymer construct. 2. The method of claim 1 , wherein the plasticizer is added at a weight ratio of plasticizer to polymer of about 1/1000 to 1/10. 3. The method of claim 1 , wherein the processing of the polymer at the high temperature comprises extrusion, injection molding, or a combination thereof. 4. The method of claim 1 , wherein at least one of the one or more additional processing operations is executed, the at least one additional processing operation comprising heating the polymer to a temperature above the glass transition temperature of the polymer or above 28° C., if the glass transition temperature of the polymer is lower than 25° C., and below the melting temperature of the polymer, if the polymer has a melting temperature above 28° C., or if the polymer does not have a melting temperature above 28° C., below the temperature that is 75° C. greater than the glass transition temperature of the polymer, or below 60° C., if 60° C. is higher than 75° C. greater than the glass transition temperature of the polymer. 5. The method of claim 1 , wherein the processing of the polymer at the high temperature comprises extrusion, injection molding, or a combination thereof to form the polymer construct, the polymer construct being a polymer tube, and wherein at least one of the one or more additional processing operations is executed, the at least one additional processing operation comprising axial expansion of the polymer tube, radial expansion of the polymer tube, or a combination of radial and axial expansion of the polymer tube after the polymer tube has been heated to a temperature above the glass transition temperature of the polymer or above 28° C., if the glass transition temperature of the polymer is lower than 25° C., and below the melting temperature of the polymer, if the polymer has a melting temperature above 28° C., or if the polymer does not have a melting temperature above 28° C., below the temperature that is 75° C. greater than the glass transition temperature of the polymer, or below 60° C., if 60° C. is higher than 75° C. greater than the glass transition temperature of the polymer of the polymer tube. 6. The method of claim 5 , additionally comprising forming a pattern in the tube to form the medical device. 7. The method of claim 1 , wherein the plasticizer is selected from the group consisting of citrate ester, phthalate esters, C1 to C16 esters of α-hydroxy acids, oligomers of up to 10 units of α-hydroxy acids, C1 to C16 esters of these oligomers of α-hydroxy acids, and combinations thereof. 8. The method of claim 1 , wherein the removal of at least 90 weight % of the plasticizer is executed prior to the medical device being packaged. 9. The method of claim 8 , wherein at least one of the one or more additional processing operations is executed, the at least one additional processing operation comprising heating the polymer to a temperature above the glass transition temperature of the polymer or above 28° C., if the glass transition temperature of the polymer is lower than 25° C., and below the melting temperature of the polymer, if the polymer has a melting temperature above 28° C., or if the polymer does not have a melting temperature above 28° C., below the temperature that is 75° C. greater than the glass transition temperature of the polymer, or below 60° C., if 60° C. is higher than 75° C. greater than the glass transition temperature of the polymer; and wherein the plasticizer is removed during, after, or both during and after the at least one additional processing operation. 10. The method of claim 9 , wherein the processing of the polymer at the high temperature comprises extrusion, injection molding, or a combination thereof to form a polymer tube, and wherein the at least one additional processing operation further comprises axial expansion of the polymer tube, radial expansion of the polymer tube, or a combination of radial and axial expansion of the polymer tube after the polymer tube has been heated to a temperature above the glass transition temperature of the polymer or above 28° C., if the glass transition temperature of the polymer is lower than 25° C., and below the melting temperature of the polymer, if the polymer has a melting temperature above 28° C., or if the polymer does not have a melting temperature above 28° C., below the temperature that is 75° C. greater than the glass transition temperature of the polymer, or below 60° C., if 60° C. is higher than 75° C. greater than the glass transition temperature of the polymer of the polymer tube. 11. The method of claim 10 , additionally comprising forming a pattern in the tube to form the medical device. 12. The method of claim 1 , wherein the heating and maintaining occurs at a pressure below 200 Torr. 13. The method of claim 1 , wherein the heating and maintaining occurs in an environment with a humidity of at least 40% rh and not more than 99% rh. 14. The method of claim 1 , wherein during the heating and maintaining, the polymer is exposed to solvent vapor of at least 20 Torr partial pressure wherein the solvent is a good solvent for the plasticizer. 15. The method of claim 14 , wherein the solvent at least partially plasticizes the polymer. 16. The method of claim 14 , wherein the partial pressure of the solvent vapor is at least 200 Torr. 17. The method of claim 14 , wher
Polymers of esters · CPC title
Thermal after-treatment {(B29C71/0063 and B29C71/0072 take precedence)} · CPC title
using liquids, e.g. solvents, swelling agents (spectacle cases, e.g. for cleaning contact lenses A45C11/04; disinfecting or sterilising contact lenses A61L12/00, using liquid substances A61L2/20; cleaning involving the use of liquid in general B08B3/00; for hydrating contact lenses B29D11/00067) · CPC title
Annealing · CPC title
Heating or cooling · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.